Research estimates that 50 to 60 percent of individuals with substance use disorder also have a co-occurring mental health condition — most commonly depression, anxiety, PTSD, or bipolar disorder. In Las Vegas, the combination of the city's high-stress environment, hospitality industry demands, and accessible substances creates a particularly high prevalence of co-occurring conditions among individuals seeking addiction treatment. Dual diagnosis programs treat both conditions simultaneously — because treating addiction without addressing the mental health condition driving it dramatically increases relapse risk.
What Is the Most Effective Treatment for Dual Diagnosis?
Integrated treatment — delivered by a clinical team trained in both addiction medicine and psychiatry — produces the best outcomes for co-occurring disorders. This model delivers substance use treatment and mental health treatment in the same program, by the same clinical team, using a unified treatment plan. Non-integrated approaches (treating addiction at one facility, mental health at another) produce significantly worse retention and recovery outcomes. The most effective behavioral therapies for dual diagnosis include DBT (for emotion regulation and suicidal ideation), CBT, and trauma-focused therapies such as EMDR for PTSD-substance use disorder comorbidity.
What Qualifies as Dual Diagnosis?
A dual diagnosis — clinically termed a co-occurring disorder (COD) — is the simultaneous presence of a substance use disorder and a diagnosable mental health condition. Common pairings include depression and alcohol use disorder, PTSD and opioid use disorder, bipolar disorder and stimulant use disorder, and anxiety disorder and benzodiazepine use disorder. To qualify for a co-occurring diagnosis, both conditions must meet diagnostic criteria under the DSM-5 — meaning the mental health symptoms exist independently of substance use (though substances may worsen them).
How Do I Get a Dual Diagnosis?
A dual diagnosis is made by a licensed clinical professional — typically a psychiatrist or clinical psychologist — following a comprehensive biopsychosocial assessment. The assessment distinguishes between substance-induced mental health symptoms (which may resolve with abstinence) and primary psychiatric disorders that exist independently of substance use. This distinction matters clinically because it guides medication decisions, therapy selection, and treatment planning. Inpatient programs in Las Vegas that offer dual diagnosis care conduct this assessment at intake, so treatment begins with accurate diagnostic clarity.